GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (OTCPK:ABDXF) » Definitions » Total Liabilities

Abingdon Health (Abingdon Health) Total Liabilities : $3.81 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Abingdon Health Total Liabilities?

Abingdon Health's Total Liabilities for the quarter that ended in Dec. 2023 was $3.81 Mil.

Abingdon Health's quarterly Total Liabilities increased from Dec. 2022 ($3.73 Mil) to Jun. 2023 ($3.85 Mil) but then declined from Jun. 2023 ($3.85 Mil) to Dec. 2023 ($3.81 Mil).

Abingdon Health's annual Total Liabilities declined from Jun. 2021 ($16.69 Mil) to Jun. 2022 ($7.81 Mil) and declined from Jun. 2022 ($7.81 Mil) to Jun. 2023 ($3.85 Mil).


Abingdon Health Total Liabilities Historical Data

The historical data trend for Abingdon Health's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Total Liabilities Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Liabilities
Get a 7-Day Free Trial 1.57 10.29 16.69 7.81 3.85

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.41 7.81 3.73 3.85 3.81

Abingdon Health Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Abingdon Health's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.677+(1.177+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=3.85

Total Liabilities=Total Assets (A: Jun. 2023 )-Total Equity (A: Jun. 2023 )
=7.653-3.799
=3.85

Abingdon Health's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.654+(1.153+0.00099999999999989
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=3.81

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=6.104-2.296
=3.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abingdon Health Total Liabilities Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Abingdon Health (Abingdon Health) Business Description

Traded in Other Exchanges
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (Abingdon Health) Headlines

From GuruFocus

AbC-19� Rapid Test Available for Purchase by Healthcare Professionals

By Business Wire Business Wire 02-16-2021